AI assisting in insulin dosing for type 2 diabetes
On December 1, 2023, JAMA Network Open published an interesting article about a study on a Voice Artificial Intelligence (Voice AI) that helps to improve a number of aspects in diabetic care, including: titration of basal insulin, increased time to optimal insulin dose, better adherence, and glycemic control in adults with type 2 diabetes. The author of the article is Ashwin Nayak, MD, MS, of the Department of Hospital Medicine, Stanford University, California.
Aston Health's vast experience in Endocrinology covers type 1 and 2 diabetes, central diabetes insipidus, tumors of the hypothalamic-pituitary region, and other endocrinology-related conditions (hypogonadism, osteoporosis, endometriosis).
Since 2011, Aston Health has been an official partner of the Federal Diabetes Registry.
Aston Health is a leader in the development of clinical patient registries in Russia and a long-term partner of the National Endocrinology Research Center in maintaining Federal Diabetes Registry. This registry is a unique project both for Russia and Europe, since it covers 5.2 million patients in 87 regions of the country and over 54 million patient-years of follow-up.
Lead Marketing Communications Manager